Bullock D Fraser 4
4 · Health Catalyst, Inc. · Filed Jul 29, 2020
Insider Transaction Report
Form 4
Bullock D Fraser
Director
Transactions
- Sale
Common Stock
2020-07-28$37.00/sh−400$14,800→ 69,614 total - Sale
Common Stock
2020-07-27$37.01/sh−1,700$62,924→ 70,014 total
Footnotes (2)
- [F1]The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1.
- [F2]Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.02 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.